We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+18.68%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.69B
AUM Growth
+$682M
Cap. Flow
-$395M
Cap. Flow %
-5.9%
Top 10 Hldgs %
54.02%
Holding
678
New
246
Increased
85
Reduced
72
Closed
235

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$85.8M
2
INDV icon
Indivior Pharmaceuticals
INDV
+$59.6M
3
BCAX
Bicara Therapeutics
BCAX
+$45.8M
4
MRUS
Merus
MRUS
+$34.4M
5
VTRS icon
Viatris
VTRS
+$30M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$102M
2
SGRY icon
Surgery Partners
SGRY
+$86.4M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$53.7M
4
IART icon
Integra LifeSciences
IART
+$42.8M
5
BNTX icon
BioNTech
BNTX
+$38.6M

Sector Composition

Rank Sector Weight
1 Healthcare 87.45%
2 Industrials 0.73%
3 Technology 0.55%
4 Financials 0.45%
5 Consumer Discretionary 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLNO
351
DELISTED
Soleno Therapeutics
SLNO
$342K 0.01%
+6,774
New +$324K
TRUP icon
352
Trupanion
TRUP
$1.13B
$339K 0.01%
+8,085
New +$315K
PAHC icon
353
Phibro Animal Health
PAHC
$1.5B
$339K 0.01%
15,055
-10,109
-40% -$195K
EHC icon
354
Encompass Health
EHC
$11.3B
$332K 0.01%
3,440
-2,862
-45% -$257K
ALV icon
355
Autoliv
ALV
$9.14B
$331K ﹤0.01%
+3,548
New +$353K
MED icon
356
Medifast
MED
$107M
$330K ﹤0.01%
+17,267
New +$333K
ZTS icon
357
Zoetis
ZTS
$32.7B
$329K ﹤0.01%
1,683
-8,395
-83% -$1.55M
GNW icon
358
Genworth Financial
GNW
$3.86B
$329K ﹤0.01%
47,993
-6,098
-11% -$40.1K
DH icon
359
Definitive Healthcare
DH
$77M
$328K ﹤0.01%
+73,387
New +$344K
HOPE icon
360
Hope Bancorp
HOPE
$1.8B
$326K ﹤0.01%
+25,959
New +$317K
CNX icon
361
CNX Resources
CNX
$4.91B
$325K ﹤0.01%
+9,972
New +$269K
AEO icon
362
American Eagle Outfitters
AEO
$2.94B
$324K ﹤0.01%
14,470
-846
-6% -$17.4K
CRVL icon
363
CorVel
CRVL
$3.18B
$322K ﹤0.01%
+2,952
New +$295K
HPE icon
364
Hewlett Packard
HPE
$58.8B
$319K ﹤0.01%
15,583
-4,571
-23% -$87.4K
AMD icon
365
Advanced Micro Devices
AMD
$700B
$317K ﹤0.01%
+1,932
New +$294K
PSA icon
366
Public Storage
PSA
$61.5B
$311K ﹤0.01%
+856
New +$278K
TLRY icon
367
Tilray
TLRY
$543M
$311K ﹤0.01%
+17,694
New +$318K
AI icon
368
C3.ai
AI
$1.38B
$309K ﹤0.01%
+12,733
New +$324K
MPLX icon
369
MPLX
MPLX
$58.6B
$304K ﹤0.01%
+6,846
New +$293K
CNDT icon
370
Conduent
CNDT
$253M
$304K ﹤0.01%
+75,446
New +$277K
CUBE icon
371
CubeSmart
CUBE
$9.61B
$299K ﹤0.01%
+5,550
New +$276K
ABG icon
372
Asbury Automotive
ABG
$4.62B
$296K ﹤0.01%
+1,241
New +$292K
AFL icon
373
Aflac
AFL
$65.5B
$296K ﹤0.01%
+2,645
New +$269K
LDOS icon
374
Leidos
LDOS
$14.4B
$296K ﹤0.01%
+1,814
New +$274K
AVGO icon
375
Broadcom
AVGO
$1.76T
$289K ﹤0.01%
+1,676
New +$269K
13 14
15
16 17

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2024 Portfolio in Review

As of Q3 2024, Deerfield Management held 678 positions worth $6.69B, up 11% from $6.01B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $395M in Q3 2024, closing 235 positions and reducing 72 holdings. Its most notable exit was Gilead Sciences, an estimated $102M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 83% a quarter earlier, followed by Industrials and Technology.

Against the trend, Deerfield Management opened a new position in Indivior Pharmaceuticals worth $49.7M.

  • Deerfield Management's largest Q3 2024 buy was Indivior Pharmaceuticals: 5,092,642 shares worth $49.7M.
  • Deerfield Management added most to Neurocrine Biosciences in Q3 2024, an estimated $85.8M increase.
  • Deerfield Management's biggest Q3 2024 reduction was Surgery Partners, cutting an estimated $86.4M.
  • Deerfield Management fully exited Gilead Sciences in Q3 2024, selling an estimated $102M.
  • Deerfield Management's ten largest holdings make up 54% of its $6.69B portfolio in Q3 2024.
  • Deerfield Management opened 246 new positions and closed 235 in Q3 2024.
  • Deerfield Management's portfolio value rose 11% quarter-over-quarter to $6.69B.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.